| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/01/2001 | WO2001013932A2 Stimulation of sperm function |
| 03/01/2001 | WO2001013908A2 Tissue volume reduction |
| 03/01/2001 | WO2001013900A2 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 03/01/2001 | WO2001013891A2 Modulation of release from dry powder formulations |
| 03/01/2001 | WO2001013887A2 Phospholipin gel |
| 03/01/2001 | WO2001013743A1 ASPARTIC AND MALIC ACID INHIBITION OF β-GLUCURONIDASE |
| 03/01/2001 | WO2001013739A1 Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same |
| 03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
| 03/01/2001 | WO2001003670A9 Method for controlled production of ultrafine microparticles and nanoparticles |
| 03/01/2001 | WO2000078948A3 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor |
| 03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 03/01/2001 | WO2000071708A3 Use of ef-ts for treating smooth muscle cell hyperplasia |
| 03/01/2001 | WO2000071146A3 Glutathione reductase for therapy and prophylaxis of aids |
| 03/01/2001 | WO2000071081A3 Methods of diagnosis and treatment of meniere disease |
| 03/01/2001 | WO2000066619A3 Means and methods for altering the functional properties in eukaryotic cells |
| 03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen |
| 03/01/2001 | WO2000059535A3 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
| 03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 03/01/2001 | WO2000029434A3 PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | DE19939982A1 Verfahren zur Isolierung und Aufreinigung von Gräserpollenallergenen A process for the isolation and purification of grass pollen allergens |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | DE10036854A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2383562A1 Peptides capable of modulating the function of cd66 (ceacam) family members |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383371A1 P193 proteins and nucleic acids, and uses thereof |
| 03/01/2001 | CA2383252A1 Treatment of cardiovascular related pathologies |
| 03/01/2001 | CA2383100A1 Aspartic and malic acid inhibition of .beta.-glucuronidase |
| 03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
| 03/01/2001 | CA2383057A1 Induced regeneration and repair of damaged neurons and nerve axon myelin |
| 03/01/2001 | CA2382852A1 Polypeptides |
| 03/01/2001 | CA2382821A1 Modulation of release from dry powder formulations |
| 03/01/2001 | CA2382817A1 Use of fibrin or fibrinogen for reducing lung tissue volume |
| 03/01/2001 | CA2382795A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382666A1 Modulation of the blood-brain barrier transporter for leptin |
| 03/01/2001 | CA2382587A1 Hm1.24 antigen expression potentiators |
| 03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2382045A1 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 03/01/2001 | CA2382016A1 Composition for growth promotion of mammals and method for growth promotion of mammals using the same |
| 03/01/2001 | CA2381969A1 A method for producing quality assured biological sample and composition containing the same |
| 03/01/2001 | CA2381571A1 Phospholipid gel |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381340A1 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2380730A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | CA2380457A1 Activatable recombinant neurotoxins |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | CA2376404A1 Meg-1 protein |
| 03/01/2001 | CA2376250A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 03/01/2001 | CA2316767A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 03/01/2001 | CA2316518A1 Use of ec-sod for treatment of systemic autoimmune diseases |
| 03/01/2001 | CA2304453A1 Use of ec-sod for treatment of systemic autoimmune diseases |
| 02/28/2001 | EP1078267A1 Assays, methods and means for modulating e2f activity |
| 02/28/2001 | EP1078099A1 Identifying peptide ligands of target proteins with target complementary library technology (tclt) |
| 02/28/2001 | EP1078093A1 Vaccines, immunotherapeutics and methods for using the same |
| 02/28/2001 | EP1078092A2 Expression vectors for stimulating an immune response and methods of using the same |
| 02/28/2001 | EP1078078A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages |
| 02/28/2001 | EP1078077A1 Nucleic acids and proteins from pineapple stem |
| 02/28/2001 | EP1078075A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 02/28/2001 | EP1078073A1 Chitinase chitin-binding fragments |
| 02/28/2001 | EP1078070A2 Human nucleic acid methylases |
| 02/28/2001 | EP1078066A2 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
| 02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
| 02/28/2001 | EP1078061A2 Protein z-dependent protease inhibitor |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078059A2 Cif130 inhibits cell cycle progression |
| 02/28/2001 | EP1078058A2 Prostate growth-associated membrane proteins |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078055A2 Dimers of the hla-b27 heavy chain extracellular domain and uses thereof |
| 02/28/2001 | EP1078054A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 02/28/2001 | EP1078046A1 97 human secreted proteins |
| 02/28/2001 | EP1078044A2 Thrombolytic agents derived from streptokinase |
| 02/28/2001 | EP1078043A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 02/28/2001 | EP1078040A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 02/28/2001 | EP1078006A1 Diagnosis and treatment of hepatic disorders |
| 02/28/2001 | EP1078005A1 Methods for amyloid removal using anti-amyloid antibodies |
| 02/28/2001 | EP1078003A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) |
| 02/28/2001 | EP1078002A1 Peptide antiangiogenic drugs |
| 02/28/2001 | EP1078001A2 Il-6 antagonist peptides |
| 02/28/2001 | EP1078000A2 Peptides |
| 02/28/2001 | EP1077999A2 Moraxella catharralis proteins |
| 02/28/2001 | EP1077997A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
| 02/28/2001 | EP1077996A1 HUMAN EDG3sb GENE |
| 02/28/2001 | EP1077995A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077991A1 Secreted proteins and polynucleotides encoding them |
| 02/28/2001 | EP1077989A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP1077936A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 02/28/2001 | EP1077728A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |